Dr. John Sims Inflammation Research Group, Amgen Corp., Seattle, USA

John Sims is a Scientific Executive Director in the Inflammation Research group at Amgen, in Seattle, Washington. His group's primary focus is investigation of the biological roles of members of the IL-1 and TNF families. Prior to Immunex's acquisition by Amgen, Dr. Sims was Vice President, Molecular Biology at Immunex.... read moreHe joined Immunex in 1984, following a PhD from Harvard University and a postdoctoral fellowship at the Medical Research Council Laboratory of Molecular Biology in Cambridge, England. Dr. Sims has published over 80 research papers as well as more than 25 review articles, mostly in the area of IL-1 and IL-1 family biology, and is an inventor on over 40 issued US and European patents.